Straddle Or Strangle?
When it comes to trading options, the straddle and the strangle are both profitable strategies – but each is best-suited for particular situations. CLICK HERE.
Ashley Hayes
A Good Place To Start Looking For Dividend Growth Stocks
When seeking out dividend growth stocks for further research, one place to look is companies that have recently increased their dividends. Here are 14 such… Read More »A Good Place To Start Looking For Dividend Growth Stocks
Untapped Opportunity In These Consumer Cyclicals
Goldman Sachs is especially bullish on the direction of the stock market this year – and sees a particular untapped opportunity in these 21 consumer… Read More »Untapped Opportunity In These Consumer Cyclicals
Shorts Of The Week
For investors interested in stocks on the way down, these two names are looking technically bearish – and could present interesting short opportunities. CLICK HERE.
Attractive Dividends In An Unloved Sector
While some utility stocks have had to slash their dividends during the pandemic, there are plenty that have continued to boost their payouts. Here are… Read More »Attractive Dividends In An Unloved Sector
The 22 Stocks With The Most New “Buy” Ratings
Analyst upgrades can help drive stock prices higher – and of all the stocks in the S&P 500, these 22 have seen the biggest increases… Read More »The 22 Stocks With The Most New “Buy” Ratings
3 Top Biotech ETFs For Q2
Of the dozen or so biotech ETFs that trade in the U.S., these three may be the best picks for Q2. CLICK HERE.
A Packaged Preferred Stock Product With An Attractive Yield
While owning individual preferred stocks provides more stability, for a “packaged” preferred stock product, consider this actively managed ETF with an attractive 8.6% yield. CLICK… Read More »A Packaged Preferred Stock Product With An Attractive Yield
A Cancer Play With A New Treatment Paradigm – And Multiple Data Readouts This Year
Radiation, surgery, chemotherapy…and electric fields? This oncology company has developed a fourth paradigm for treating cancer – and has multiple data readouts this year that… Read More »A Cancer Play With A New Treatment Paradigm – And Multiple Data Readouts This Year
The Most Largely Undervalued Large-Cap Stock
This stock, just two-and-a-half months old, may be the most wildly undervalued large-cap stock on the market – and it’s expected to soon declare a… Read More »The Most Largely Undervalued Large-Cap Stock